Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 2,741 | 1,696 | 1,387 | 6,274 | 272 |
| Cost of Goods | 1,212 | 781 | 616 | 1,347 | 131 |
| Gross Profit | 1,529 | 915 | 771 | 4,927 | 141 |
| Operating Expenses | 3,112 | 3,583 | 4,067 | 3,563 | 3,089 |
| Operating Income | -1,371 | -1,887 | -2,680 | 1,711 | -2,817 |
| Other Income | -248 | 386 | 409 | 74 | -534 |
| Pre-tax Income | -1,619 | -1,501 | -2,271 | 1,785 | -3,351 |
| Net Income Continuous | -1,619 | -1,501 | -2,271 | 1,785 | -3,351 |
| Net Income | $-1,619 | $-1,501 | $-2,271 | $1,785 | $-3,351 |
| EPS Basic Total Ops | -0.05 | -0.03 | -0.07 | 0.06 | -0.11 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.07 | 0.06 | -0.11 |
| EPS Diluted Total Ops | -0.05 | -0.03 | -0.07 | 0.06 | -0.11 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.07 | 0.06 | -0.11 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.03 | -0.07 | 0.06 | -0.11 |
| EBITDA(a) | $-1,307 | $-1,820 | $-2,614 | $1,969 | $-2,651 |